Genetics of Coronary Artery Disease in Alaska Natives

Information

  • Research Project
  • 7650226
  • ApplicationId
    7650226
  • Core Project Number
    U01HL064244
  • Full Project Number
    5U01HL064244-10
  • Serial Number
    64244
  • FOA Number
    RFA-HL-05-102
  • Sub Project Id
  • Project Start Date
    8/21/2000 - 25 years ago
  • Project End Date
    6/30/2013 - 12 years ago
  • Program Officer Name
    FABSITZ, RICHARD
  • Budget Start Date
    7/1/2009 - 16 years ago
  • Budget End Date
    6/30/2013 - 12 years ago
  • Fiscal Year
    2009
  • Support Year
    10
  • Suffix
  • Award Notice Date
    7/17/2009 - 16 years ago

Genetics of Coronary Artery Disease in Alaska Natives

DESCRIPTION (provided by applicant): Cardiovascular disease (CVD) is increasing among Alaska Natives. The Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study has been examining CVD and its risk factors by conducting a family genetic study among Eskimos residing in eight villages and the town of Nome in the Norton Sound Region. This application proposes to extend the GOCADAN study to pursue the following aims: 1) Expand the genetic studies that will emphasize the genome scan approach. The complete genome scan of 1,214 members, who are nearly all part of one extended pedigree, will be used to identify quantitative trait loci for subclinical CVD and CVD risk factors and narrow the regions of interest be fine mapping. 2) Re-examine the family members so that changes in risk factors can be analyzed and genetic effects on changes estimated. Surveillance for CVD events will be instituted, including annual mortality surveillance and follow-up of nonfatal events uncovered at the time of the re-exam. Advantages of GOCADAN include: 1) It provides health data on an underserved ethnic group. 2) The large extended pedigree improves the chances of detecting significant loci for subclinical CVD and its risk factors. 3) Data from carotid ultrasound measures will improve understanding of mechanisms of vascular disease and the genetics of CVD. 4) A unique constellation of risk factors with low rates of several risk factors, such as diabetes and hypertension, but high levels of inflammation and rates of smoking, provides a population uniquely suited to examine the roles of inflammatory markers in CVD. GOCADAN will lead the valuable therapeutic and prevention strategies for this and other populations in the United States and the world, where the epidemics of obesity, diabetes, and CVD are increasing rapidly.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    U01
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    566398
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:566398\
  • Funding Mechanism
    Research Projects
  • Study Section
    ZHL1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MEDSTAR RESEARCH INSTITUTE
  • Organization Department
  • Organization DUNS
    189030067
  • Organization City
    HYATTSVILLE
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    20782
  • Organization District
    UNITED STATES